Pathophysiologische Grundlagen der Myokardhypertrophie
Vorsitz: L. S. Maier (Göttingen), S. Rohrbach (Giessen)
| (V1108) | S151A mutation in the Delta-Sarcoglycan gene causes a mild phenotype of cardiomyopathy |
| R. Bauer, D. Rutschow, S. Schinkel, C. Göhringer, H. A. Katus, O. J. Müller (Heidelberg) | |
| (V1109) | Desensitization and Overcompensation of Proteasome Signaling in Isoproterenol Induced Cardiac Hypertrophy |
| O. Drews, O. Tsukamoto, D. Liem, J. Streicher, Y. Wang, P. Ping (Heidelberg; Osaka, JP; Los Angeles, US) | |
| (V1110) | Htatip2 hemmt kardiomyozytäre Hypertrophie |
| A. Grund, N. Froese, O. J. Müller, U. Schrameck, J. Bauersachs, J. Heineke (Hannover, Heidelberg) | |
| (V1111) | Role of late INa in the pathogenesis of pressure overload-induced hypertrophy and heart failure |
| N. Hartmann, S. T. Sossalla, K. Toischer, T. Schulte, S. Wagner, G. Hasenfuß, L. S. Maier (Göttingen) | |
| (V1112) | Generation of Transgenic Zebrafish to Study ILK Signalling in vivo |
| D. Köhler, B. Meder, C. Heid, S. Just, K. Frese, T. Dahme, H. A. Katus, W. Rottbauer (Heidelberg, Ulm) | |
| (V1113) | RAPL, A New Mediator Of Angiogenesis, mediates Integrin Endocytosis In Endothelial Cells and Vessel Stability in vivo |
| Y. Manavski, G. Carmona, J. Kroll, S. Dimmeler, E. Chavakis (Frankfurt am Main, Mannheim) |